-
Články
Top novinky
Reklama- Vzdělávání
- Časopisy
Top články
Nové číslo
- Témata
Top novinky
Reklama- Kongresy
- Videa
- Podcasty
Nové podcasty
Reklama- Kariéra
Doporučené pozice
Reklama- Praxe
Top novinky
ReklamaMonitoring and Evaluating Progress towards Universal Health Coverage in Estonia
article has not abstract
Published in the journal: . PLoS Med 11(9): e32767. doi:10.1371/journal.pmed.1001677
Category: Collection Review
doi: https://doi.org/10.1371/journal.pmed.1001677Summary
article has not abstract
This paper is part of the PLOS Universal Health Coverage Collection. This is the summary of the Estonia country case study. The full paper is available as Supporting Information file Text S1.
Background
Since regaining its independence in 1991, Estonia has conducted radical health system reforms. The Estonian health system is based on mandatory, solidarity-based insurance and universal access to health services made available by providers operating under private law with primary health care (PHC) playing a central role. The financing of health care is mainly organized through the semi-autonomous Estonian Health Insurance Fund (EHIF), which covers about 70% of total health expenditure in the country. Life expectancy at birth (LE) among a population of 1.3 million reached 76.2 years in 2012.
Universal Health Coverage: The Policy Context
Health policy issues are mostly covered at the national level, while municipalities have only a limited role in public health policy through local Health in All Policies (inclusion of health considerations in policy making across different sectors that influence health) and implementation of selected national public health programmes. Currently, the main policy document is the National Health Plan (NHP) 2009–2020 [1], which contains a wide set of measurable targets with specific indicators that are reported annually with outcome reviews every second year.
Monitoring and Evaluation for UHC
While the NHP was adopted as an overarching health policy only in 2008, there is a longer tradition in Estonia regarding area-specific health strategies [2]–[4] and institutional development plans [5]. These strategies and plans all have specialised indicator frameworks for targeting, monitoring, and assessing progress made in improving population health. All these specific policy documents feed into the overall health system monitoring and assessment system, thus enabling improved governance and policy development.
The monitoring and reporting system of the NHP is further supported by the health system performance assessment (HSPA) [6], explicitly linked to the health system framework that prioritises health outcomes, financial protection, and responsiveness to need, which are also the main principles of UHC.
A UHC-specific monitoring framework is not present in Estonia but its main components are present in the NHP and HSPA indicator frameworks.
Progress towards UHC in Estonia
Financial Protection
In Estonia, population coverage with health insurance is 95%, and the entire population is covered for emergency care. Share of out-of-pocket (OOP) payments declined from 25% in 2006 to 18% in 2012 (Figure 1) [7],[8]; the remainder was covered by public funds (mainly health insurance). The main source of OOP payments is co-payments for outpatient medication and adult dental care.
Fig. 1.
Out-of-pocket payments as a proportion of total household expenditure by quintiles <em class="ref">[8]</em>. Household budget data show that in 2011 the proportion of high health expenditures (>20% of capacity to pay) was lowest among the poorest and richest income quintiles with 6.5% and 3.5%, respectively, while in the second income quintile this proportion reached 12%. As a result of OOP payments, about 1% of households in the poorest quintile faced poverty in 2011 compared to almost 9% in 2004.
Responsiveness to Need
Access to health care services was considered to be good or very good in Estonia by 55% of the adult population and 79% was satisfied with the quality of care in 2012 [9].
Coverage with services is monitored using utilization data. Service coverage is further supported by a PHC quality bonus system [10], which includes indicators for monitoring disease prevention, chronic disease management, and additional activities, as surgical and gynaecological procedures at the PHC level use annually increasing targets for all indicators (45 in 2013).
Efficiency of service provision is important for identifying possibilities for extending UHC with available resources. The volume of acute care hospital beds has decreased significantly over the past 20 years and by 2011 reached 350 per 100,000 people (below the European Union [EU] average) [11]. The average length of these acute care stays decreased from 17.4 days in 1990 to 5.5 days in 2011. The number of physicians has remained stable (326 per 100,000 in 2011) with a nurse to physician ratio of two (approximately three in the EU) since the 1990s.
Service quality measurement is one of the areas in development in Estonia with a first set of health care quality indicators for acute care hospitals published in 2011 [12]. In parallel, 92% of people were satisfied with their last visit to a family doctor, 93% with their last hospital visit, and 88% with their last outpatient specialist visit in 2012 [9].
Health Outcomes
LE has increased by about 10 years from its lowest in 1994 to 76.2 years in 2012 [13]. However, a ten-year gender gap favouring women has persisted since 1991. The LE increase has been driven by reductions in cardiovascular, injury, and cancer mortality (accounting for 93% of LE improvement during 2000–2008), whereas diabetes and alcohol-related conditions slowed the LE increase (Figure 2) [6].
Fig. 2.
Life expectancy change in Estonia between 2000 and 2008 by cause of death <em class="ref">[6]</em>. Health inequalities in Estonia are mainly related to socio-economic factors; the proportion of individuals assessing their health as good or very good is persistently 20 or more percentage points higher among the highly educated and high-income groups compared to those with the lowest education levels [10],[14].
Conclusions and Recommendations
Estonia has been successful in achieving UHC although work remains to reach absolute universal coverage, such as in extending health insurance coverage, reducing the share of OOP payments, and addressing health inequalities.
The Estonian experience has shown that comprehensive policy monitoring and assessment enables the monitoring of UHC even in the absence of a dedicated framework. In particular, UHC monitoring can be facilitated if extensive routine data sources are developed, linked, and integrated through comprehensive IT solutions. However, a specific focus on UHC and creating a dedicated monitoring framework within the existing system would target existing data gaps and move UHC into strong policy focus for systematic policy development.
Supporting Information
Zdroje
1. Ministry of Social Affairs (2008) National Health Plan 2009–2020. Available: http://www.sm.ee/fileadmin/meedia/Dokumendid/Tervisevaldkond/Rahvatervis/RTA/ERTA_english.pdf. Accessed 5 March 2014.
2. Ministry of Social Affairs (2005) Estonian National Strategy for Prevention of Cardiovascular Diseases 2005–2020. Tallinn: Ministry of Social Affairs.
3. Ministry of Social Affairs (2007) National Cancer Strategy 2007–2015. Available: http://www2.tai.ee/teated/arenduskeskus/Vahistrateegia/National_Cancer_strategy_2007_2015engpdf. Accessed 5 March 2014.
4. Ministry of Social Affairs (2007) Estonian National HIV/AIDS strategy 2006–2015. Available: http://www.sm.ee/fileadmin/meedia/Dokumendid/Tervisevaldkond/Tervishoid/Riiklik_HIV_ja_AIDSi_strateegia_aastateks_2006-2015.pdf. Accessed 5 March 2014.
5. Estonian Health Insurance Fund (2012) Eesti Haigekassa arengukava 2012–2015. [Strategic Development Plan of Estonian Health Insurance Fund 2012-2015]. Available: http://www.haigekassa.ee/uploads/userfiles/Otsus_nr23_arengukava_2012_2015.pdf. Accessed 5 March 2014.
6. WHO Regional Office for Europe (2010) Estonia, Health System Performance Assessment: 2009 snapshot. Copenhagen: WHO Regional Office for Europe.
7. National Institute for Health Development (2014) National health accounts. Available: http://bit.ly/1p0UAOL. Accessed 5 March 2014.
8. Võrk A (2014) Out-of-pocket payment and catastrophic expenditure in Estonia 2000–2011. Copenhagen: WHO Regional Office for Europe. In press.
9. Ministry of Social Affairs, Estonian Health Insurance Fund(2013) Elanike hinnangud tervisele ja arstiabile 2012. [Population satisfaction with health and healthcare 2012]. Available: http://www.haigekassa.ee/uploads/userfiles/Elanike%20hinnangud%20tervisele%20ja%20arstiabile_2012_raport_GfK.pdf. Accessed 5 March 2014.
10. Lai T, Habicht T, Kahur K, Kiivet RA, Reinap M, et al.. (2013) Estonia: health system review. Health systems in transition. Copenhagen: WHO Office for European Region.
11. WHO Regional Office for Europe (2014) European Health for All Database (HFA-DB). Available: http://data.euro.whoint/hfadb. Accessed 5 March 2014.
12. Estonian Health Insurance Fund. (2013) Estonian Health Insurance Fund. http://www.haigekassa.ee/eng/. Accessed 5 March 2014.
13. Statistics Estonia (2014) Life expectancy by sex and age. Available: http://bit.ly/1p0UIO9. Accessed 5 March 2014.
14. National Institute for Health Development (2013) Self-estimated health by gender and education. Tallinn: Institute for Health Development.
Štítky
Interní lékařství
Článek vyšel v časopisePLOS Medicine
Nejčtenější tento týden
2014 Číslo 9- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Biomarker NT-proBNP má v praxi široké využití. Usnadněte si jeho vyšetření POCT analyzátorem Afias 1
- S MUDr. Petrou Vysočanovou o hypertenzi u diabetiků: Jak léčit skutečně účinně a bez zbytečných rizik?
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
- Antikoagulační léčba u pacientů před operačními výkony
-
Všechny články tohoto čísla
- Monitoring and Evaluating Progress towards Universal Health Coverage in Ghana
- Sorting Reality from What We Think We Know About Breast Cancer in Africa
- The PLOS “Monitoring Universal Health Coverage” Collection: Managing Expectations
- Monitoring and Evaluating Progress towards Universal Health Coverage in India
- Monitoring and Evaluating Progress towards Universal Health Coverage in Tanzania
- Monitoring and Evaluating Progress towards Universal Health Coverage in Brazil
- Monitoring and Evaluating Progress towards Universal Health Coverage in Thailand
- Monitoring and Evaluating Progress towards Universal Health Coverage in Estonia
- Monitoring and Evaluating Progress towards Universal Health Coverage in Chile
- Prioritizing Pregnant Women for Long-Lasting Insecticide Treated Nets through Antenatal Care Clinics
- Financial Risk Protection and Universal Health Coverage: Evidence and Measurement Challenges
- Convergence of Mortality Rates among Patients on Antiretroviral Therapy in South Africa and North America
- Malaria Prevention during Pregnancy—Is There a Next Step Forward?
- Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention
- Intimate Partner Violence and Reproductive Coercion: Global Barriers to Women's Reproductive Control
- Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis
- Readmissions after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia among Young and Middle-Aged Adults: A Retrospective Observational Cohort Study
- Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial
- Equity-Oriented Monitoring in the Context of Universal Health Coverage
- The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis
- Effective Coverage: A Metric for Monitoring Universal Health Coverage
- Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
- Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
- Oral Cholera Vaccine Development and Use in Vietnam
- Monitoring and Evaluating Progress towards Universal Health Coverage in Bangladesh
- Monitoring and Evaluating Progress towards Universal Health Coverage in South Africa
- Monitoring and Evaluating Progress towards Universal Health Coverage in Ethiopia
- Preventing Acute Malnutrition in Young Children: Improving the Evidence for Current and Future Practice
- Monitoring and Evaluating Progress towards Universal Health Coverage in Singapore
- Monitoring and Evaluating Progress towards Universal Health Coverage in China
- Monitoring and Evaluating Progress towards Universal Health Coverage in Tunisia
- Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis
- WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
- Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial
- Preventing Acute Malnutrition among Young Children in Crises: A Prospective Intervention Study in Niger
- Monitoring Progress towards Universal Health Coverage at Country and Global Levels
- Monitoring Intervention Coverage in the Context of Universal Health Coverage
- Regular Breakfast Consumption and Type 2 Diabetes Risk Markers in 9- to 10-Year-Old Children in the Child Heart and Health Study in England (CHASE): A Cross-Sectional Analysis
- Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
- PLOS Medicine
- Archiv čísel
- Aktuální číslo
- Informace o časopisu
Nejčtenější v tomto čísle- Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
- Monitoring and Evaluating Progress towards Universal Health Coverage in Chile
- Malaria Prevention during Pregnancy—Is There a Next Step Forward?
- Financial Risk Protection and Universal Health Coverage: Evidence and Measurement Challenges
Kurzy
Zvyšte si kvalifikaci online z pohodlí domova
Autoři: prof. MUDr. Vladimír Palička, CSc., Dr.h.c., doc. MUDr. Václav Vyskočil, Ph.D., MUDr. Petr Kasalický, CSc., MUDr. Jan Rosa, Ing. Pavel Havlík, Ing. Jan Adam, Hana Hejnová, DiS., Jana Křenková
Autoři: MUDr. Irena Krčmová, CSc.
Autoři: MDDr. Eleonóra Ivančová, PhD., MHA
Autoři: prof. MUDr. Eva Kubala Havrdová, DrSc.
Všechny kurzyPřihlášení#ADS_BOTTOM_SCRIPTS#Zapomenuté hesloZadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.
- Vzdělávání